HomeTLT • CVE
add
Theralase Technologies Inc
Previous close
$0.17
Day range
$0.16 - $0.17
Year range
$0.15 - $0.31
Market cap
37.92M CAD
Avg Volume
132.91K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 363.61K | 11.68% |
Operating expense | 1.22M | 12.24% |
Net income | -991.02K | -12.21% |
Net profit margin | -272.55 | -0.47% |
Earnings per share | — | — |
EBITDA | -952.72K | -15.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 43.91K | -97.09% |
Total assets | 3.28M | -21.25% |
Total liabilities | 1.37M | 28.36% |
Total equity | 1.91M | — |
Shares outstanding | 235.13M | — |
Price to book | 17.00 | — |
Return on assets | -79.73% | — |
Return on capital | -115.49% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -991.02K | -12.21% |
Cash from operations | -1.25M | -16.29% |
Cash from investing | -11.44K | 81.94% |
Cash from financing | 1.07M | 443.64% |
Net change in cash | -191.11K | 79.65% |
Free cash flow | -812.78K | -21.82% |
About
Founded
1989
Headquarters
Website
Employees
20